Showing 20,281 - 20,300 results of 21,342 for search '(( significant decrease decrease ) OR ( significant ((17 decrease) OR (a decrease)) ))', query time: 0.71s Refine Results
  1. 20281

    Baseline characteristics of participants. by Mei Zhou (269746)

    Published 2025
    “…</p><p>Results</p><p>After DRG implementation, the logarithmic mean of total hospitalization expenditures decreased significantly (3.914 ± 0.837 vs. 3.872 ± 1.004), while rates of unplanned readmissions, unplanned reoperations, postoperative complications, and patient complaints within 30 days increased significantly (3.784% vs 4.214%, 0.083% vs 0.166%, 0.207% vs 0.258%, 3.741% vs 5.133%). …”
  2. 20282

    The framework diagram of this study. by Mei Zhou (269746)

    Published 2025
    “…</p><p>Results</p><p>After DRG implementation, the logarithmic mean of total hospitalization expenditures decreased significantly (3.914 ± 0.837 vs. 3.872 ± 1.004), while rates of unplanned readmissions, unplanned reoperations, postoperative complications, and patient complaints within 30 days increased significantly (3.784% vs 4.214%, 0.083% vs 0.166%, 0.207% vs 0.258%, 3.741% vs 5.133%). …”
  3. 20283

    Table 1_Exploring the alleviating effects of Bifidobacterium metabolite lactic acid on non-alcoholic steatohepatitis through the gut-liver axis.docx by Hongmei Zhao (250090)

    Published 2025
    “…</p>Results<p>In vivo findings indicated that, in comparison to CBX group (Control group without antibiotic treatment), NAFLD/CBX group (NAFLD group without antibiotic administration) and NAFLD/ABX group (NAFLD group with antibiotic administration) exhibited increased liver-to-body weight ratio, higher lipid droplet accumulation, aggravated liver histopathological damage, and elevated levels of AST (Aspartate Aminotransferase), ALT (Alanine Aminotransferase), TC (Total Cholesterol), TG (Triglycerides), LDL-C (Low-Density Lipoprotein Cholesterol), IL-6 (Interleukin-6), TNF-α (Tumor Necrosis Factor-alpha), IL-1β (Interleukin-1 beta), and NLRP3-related molecules, while HDL-C (High-Density Lipoprotein Cholesterol) levels significantly decreased. Intervention with Bifidobacterium significantly reversed these adverse changes. …”
  4. 20284

    Data Sheet 1_Lysate of Parabacteroides distasonis prevents severe forms of experimental autoimmune encephalomyelitis by modulating the priming of T cell response.docx by Zuzana Jiraskova Zakostelska (6386825)

    Published 2024
    “…EAE induction was the main factor in altering the gut microbiota, decreasing the abundance of lactobacilli and segmented filamentous bacteria. …”
  5. 20285

    Data Sheet 1_The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout.zip by Zeng Zhang (299463)

    Published 2025
    “…Background<p>Interleukin-6 (IL-6) is a pleiotropic cytokine, with specific effects depending on the immune microenvironment. …”
  6. 20286

    Data Sheet 3_The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout.zip by Zeng Zhang (299463)

    Published 2025
    “…Background<p>Interleukin-6 (IL-6) is a pleiotropic cytokine, with specific effects depending on the immune microenvironment. …”
  7. 20287

    Table 1_The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout.xls by Zeng Zhang (299463)

    Published 2025
    “…Background<p>Interleukin-6 (IL-6) is a pleiotropic cytokine, with specific effects depending on the immune microenvironment. …”
  8. 20288

    Image 1_The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout.jpeg by Zeng Zhang (299463)

    Published 2025
    “…Background<p>Interleukin-6 (IL-6) is a pleiotropic cytokine, with specific effects depending on the immune microenvironment. …”
  9. 20289

    Data Sheet 5_The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout.zip by Zeng Zhang (299463)

    Published 2025
    “…Background<p>Interleukin-6 (IL-6) is a pleiotropic cytokine, with specific effects depending on the immune microenvironment. …”
  10. 20290

    Data Sheet 2_The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout.zip by Zeng Zhang (299463)

    Published 2025
    “…Background<p>Interleukin-6 (IL-6) is a pleiotropic cytokine, with specific effects depending on the immune microenvironment. …”
  11. 20291

    Data Sheet 8_The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout.zip by Zeng Zhang (299463)

    Published 2025
    “…Background<p>Interleukin-6 (IL-6) is a pleiotropic cytokine, with specific effects depending on the immune microenvironment. …”
  12. 20292

    Data Sheet 6_The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout.zip by Zeng Zhang (299463)

    Published 2025
    “…Background<p>Interleukin-6 (IL-6) is a pleiotropic cytokine, with specific effects depending on the immune microenvironment. …”
  13. 20293

    Data Sheet 7_The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout.zip by Zeng Zhang (299463)

    Published 2025
    “…Background<p>Interleukin-6 (IL-6) is a pleiotropic cytokine, with specific effects depending on the immune microenvironment. …”
  14. 20294

    Data Sheet 4_The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout.zip by Zeng Zhang (299463)

    Published 2025
    “…Background<p>Interleukin-6 (IL-6) is a pleiotropic cytokine, with specific effects depending on the immune microenvironment. …”
  15. 20295

    Quantitative real-time PCR primer sequences. by Lydie M. O. Barbeau (5941712)

    Published 2025
    “…<div><p>In the last decade, advancements in understanding the genetic landscape of lung squamous cell carcinoma (LUSC) have significantly impacted therapy development. Immune checkpoint inhibitors (ICI) have shown great promise, improving overall and progression-free survival in approximately 25% of the patients. …”
  16. 20296

    MAP1LC3C shRNA sequences. by Lydie M. O. Barbeau (5941712)

    Published 2025
    “…<div><p>In the last decade, advancements in understanding the genetic landscape of lung squamous cell carcinoma (LUSC) have significantly impacted therapy development. Immune checkpoint inhibitors (ICI) have shown great promise, improving overall and progression-free survival in approximately 25% of the patients. …”
  17. 20297

    Data Sheet 1_Effect of Fangxia-Dihuang Decoction on doxorubicin-induced cognitive impairment in breast cancer animal model.docx by Xuan Wang (55634)

    Published 2025
    “…The results of blood routine and cardiac HE staining showed that compared with the 4T1 group, the serum ALT, AST, CK, LDH, and CKMB in DOX group mice were significantly increased (P<0.05). After FXDH administration, all indicators in mice were decreased, but there was no statistical difference. …”
  18. 20298

    Video 1_Effect of Fangxia-Dihuang Decoction on doxorubicin-induced cognitive impairment in breast cancer animal model.mp4 by Xuan Wang (55634)

    Published 2025
    “…The results of blood routine and cardiac HE staining showed that compared with the 4T1 group, the serum ALT, AST, CK, LDH, and CKMB in DOX group mice were significantly increased (P<0.05). After FXDH administration, all indicators in mice were decreased, but there was no statistical difference. …”
  19. 20299

    Video 1_Ferrostatin-1 improves acute sepsis-induced cardiomyopathy via inhibiting neutrophil infiltration through impaired chemokine axis.mp4 by Jialin Li (382950)

    Published 2024
    “…Consistently, expression of neutrophil associated chemokines (Ccrl2, Cxcl2, Cxcl3 and Cxcl5) as well as extracellular matrix (ECM) degradation enzymes (Adamts1, Adamts4, Adamts9 and Mmp8) significantly decreased in Fer-1 pre-treated CLP heart.…”
  20. 20300

    Data Sheet 1_Ferrostatin-1 improves acute sepsis-induced cardiomyopathy via inhibiting neutrophil infiltration through impaired chemokine axis.zip by Jialin Li (382950)

    Published 2024
    “…Consistently, expression of neutrophil associated chemokines (Ccrl2, Cxcl2, Cxcl3 and Cxcl5) as well as extracellular matrix (ECM) degradation enzymes (Adamts1, Adamts4, Adamts9 and Mmp8) significantly decreased in Fer-1 pre-treated CLP heart.…”